- Home
- IE vs DYN Comparison
IE vs DYN Comparison
Compare IE & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IE | DYN |
|---|---|---|
| Founded | 2020 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.0B |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IE | DYN |
|---|---|---|
| Price | $10.78 | $18.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 14 |
| Target Price | $18.50 | ★ $37.00 |
| AVG Volume (30 Days) | 2.0M | ★ 2.3M |
| Earning Date | 05-05-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.79 | N/A |
| Revenue | ★ $3,244,000.00 | N/A |
| Revenue This Year | $32.09 | N/A |
| Revenue Next Year | $11.37 | N/A |
| P/E Ratio | $14.11 | ★ N/A |
| Revenue Growth | ★ 11.82 | N/A |
| 52 Week Low | $4.50 | $7.01 |
| 52 Week High | $21.55 | $25.00 |
Technical Indicators
Market Signals| Indicator | IE | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 27.20 | 56.31 |
| Support Level | $8.69 | $18.32 |
| Resistance Level | $13.44 | $20.08 |
| Average True Range (ATR) | 0.71 | 1.19 |
| MACD | -0.12 | 0.11 |
| Stochastic Oscillator | 5.56 | 59.52 |
Price Performance
Historical ComparisonAbout IE Ivanhoe Electric Inc.
Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.